Drug Profile
RO 6924963
Alternative Names: 11C-labelled RO 6924963; [11C]RO 6924963; Carbon 11 RO 6924963; RO6924963Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Imaging agents; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Alzheimer's-disease(Diagnosis) in USA (IV, Injection)
- 01 Aug 2014 Phase-I clinical trials in Alzheimer's disease (Diagnosis) in USA (IV)
- 17 Jul 2014 Preclinical trials in Alzheimer's disease (diagnosis) in USA (IV)